期刊文献+

Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer 被引量:12

Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer
下载PDF
导出
摘要 AIM: To explore the effect and significance of inhibitor of growth 1 (ING1) gene in carcinogenesis and progression of human sporadic colorectal cancer. METHODS: mRNA expression, mutation, and loss of heterozygosity (LOH) of ING1 gene in 35 specimens of sporadic colorectal cancer tissues and the matched normal mucous membrane tissues were detected by semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR), PCR-single strain conformation polymorphism (PCR-SSCP) and PCR-simple sequence length polymorphism (PCR-SSLP) using microsatellite markers, respectively. RESULTS: The average ratios of light intensities of p33^ING1b and p47^ING1a mRNA expression in the cancerous tissues were significantly lower than those in normal tissues. The difference between the two mRNA splices was not significant in the matched tissues. In addition, the ratios of light intensities of p33^ING1b and p47^ING1a mRNA expression in the cancerous tissues of Dukes' stages C and D were significantly lower than those in cancerous tissues of Dukes' stages A and B. However, no mutation of ING1 gene was detected in all 35 cases; only 4 cases of LOH (11.4%) were found. CONCLUSION: p33^ING1b and p47^ING1a mRNA expressions are closely related with the carcinogenesis and progression of human sporadic colorectal cancer. No mutation of ING1 gene is found, and there are only few LOH in sporadic colorectal cancers. These might not be the main reasons for the down regulation of ING1 expression. Its low expression may happen in transcription or post-transcription. AIM: To explore the effect and significance of inhibitor of growth 1 (ING1) gene in carcinogenesis and progression of human sporadic colorectal cancer.METHODS: mRNA expression, mutation, and loss of heterozygosity (LOH) of ING1 gene in 35 specimens of sporadic colorectal cancer tissues and the matched normal mucous membrane tissues were detected by semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR),PCR-single strain conformation polymorphism (PCR-SSCP)and PCR-simple sequence length polymorphism (PCR-SSLP)using microsatellite markers, respectively.RESULTS: The average ratios of light intensities of p33ING1b and p47ING1a mRNA expression in the cancerous tissues were significantly lower than those in normal tissues.The difference between the two mRNA splices was not significant in the matched tissues. In addition, the ratios of light intensities of p33INB1b and p47ING1a mRNA expression in the cancerous tissues of Dukes' stages C and D were significantly lower than those in cancerous tissues of Dukes'stages A and B. However, no mutation of ING1 gene was detected in all 35 cases; only 4 cases of LOH (11.4%)were found.CONCLUSION: p33ING1b and p47ING1a mRNA expressions are closely related with the carcinogenesis and progression of human sporadic colorectal cancer. No mutation of ING1gene is found, and there are only few LOH in sporadic colorectal cancers. These might not be the main reasons for the down regulation of ING1 expression. Its low expression may happen in transcription or post-transcription.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第39期6120-6124,共5页 世界胃肠病学杂志(英文版)
基金 Supported by the Guangxi Provincial Scientific Fund for the Returned Overseas Chinese Scholars, No. 0342018Key Research Fund from Public Health Bureau of Guangxi, No. 200206
关键词 Colorectal cancer Inhibitor of growth 1(ING1) EXPRESSION MUTATION Loss of heterozygosity 遗传因素 结肠癌 直肠癌 病理机制 基因表达
  • 相关文献

参考文献3

二级参考文献22

  • 1Garkevtsev I, Kazarov A,Gudkov A,et al. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nature Genet, 1996,14:415-420.
  • 2Ma D, Lawless D,Riabowol K. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation(corretion). Nature Genet,1999,23:273.
  • 3Gavtsev I,Grigorian IA,Gudkov AV,et al.The candidate tumor suppressor p33ING1 cooperates with p53 in cell growth control. Nature,1998,391:295-298.
  • 4Garkevtsev I,Boland D,Riabowol K,et al.Specific monoclonal antibody raised against the p33ING1 tumor suppressor. Hybridoma,1997,16:537-540.
  • 5Gunduz M,Ouchida M,Fukushima K,et al.Genomic structure of the human ING1 gene and tumor specific mutations detected in head and neck squamous cell carcinoma. Cancer Res,2000,60:3143-3146.
  • 6Zeremski M,Horrigan SK,Grigorian IA,et al. Localization of candidate tumor suppressor gene ING1 to human chromosome 13q34. Somatic Cell Mol Genent,1997,23:233-236.
  • 7Oki E,Maehara Y,Tokunaga E,et al.Reduced expression of p33ING1 and the relationship with p53 expression in human gastric cancer. Cancer lett,1999,147:157-162.
  • 8Sarela AI,Farmery SM,Markham AF,et al.The candidate tumor suppressor gene ING1 is retained in colorectal carcinomas. Eur J Cancer,1999,35:1264-1267.
  • 9Toyama T,Iwase H, Waston P. Suppression of ING1 expression of p33ING1 mRNA in sporadic breast cancer. Oncogene,1999,18:5187-5193.
  • 10Gavtsev I, Riabowol K. Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor. Mol Cell Biol,1997,17:2014-2019.

共引文献38

同被引文献41

引证文献12

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部